MoviePass Files for Public Offering

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
MoviePass Files for Public Offering

© Daniel Boczarski / Getty Images for MoviePass

While details are scarce, your chance to buy stock in a standalone MoviePass is one step closer Thursday. The discount movie-ticket program is currently controlled by Helios and Matheson Analytics Inc. (NASDAQ: HMNY), whose stock traded at $0.014 just before noon today.

Helios announced Thursday that it has filed a confidential draft registration Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a direct offering of stock in a new company called MoviePass Entertainment Holdings that will be a subsidiary of Helios and take ownership of MoviePass shares and related assets held by the parent company.

According to the Helios announcement, the filing proposes the distribution by Helios and Matheson of a minority of its shares of MoviePass Entertainment common stock as a dividend to stockholders of Helios shares as of a record date that is yet to be determined. Helios said it plans to retain control of MoviePass Entertainment after any such distribution.

[nativounit]

Helios expects to begin distributing the shares after the SEC completes its review process and declares the Form S-1 registration statement effective. The distribution is subject to a number of other conditions, including the approved listing of shares of MoviePass Entertainment on Nasdaq or an alternate trading market and Helios being permitted to distribute MoviePass Entertainment shares under Delaware law, of which there is no assurance.

On Wednesday, Helios completed the private placement of 333.3 million common units at $0.0163 per share raising $5.4 million in gross proceeds. Each common unit includes one share of common stock and two warrants to purchase additional common stock in the future. The warrants are not exercisable until six months after the date of the closing and the Series C (priced at $0.0163 per common share) will have an exercise term of five years and the Series D (priced at $0.0163 per share) and the Series E warrants (priced at $1.00 per share) will have an exercise term of one year.

[recirclink id=522422]

[wallst_email_signup]

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618